Short duration, high dose, alternating chemotherapy in metastatic neuroblastoma. (ENSG 3C induction regimen). The European Neuroblastoma Study Group.

Fifty-one children, aged from 15 months to 13 years 5 months with metastatic neuroblastoma presenting sequentially at the participating institutions received four 3 to 4 weekly courses of high dose multiagent chemotherapy. High dose cisplatin (200 mg m-2) combined with etoposide (500 mg m-2), HIPE,...

Descripción completa

Detalles Bibliográficos
Autores principales: Pinkerton, C. R., Zucker, J. M., Hartmann, O., Pritchard, J., Broadbent, V., Morris-Jones, P., Breatnach, F., Craft, A. E., Pearson, A. D., Wallendszus, K. R.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1990
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971805/
https://www.ncbi.nlm.nih.gov/pubmed/2386751

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971805/
https://www.ncbi.nlm.nih.gov/pubmed/2386751

Ejemplares similares